Last reviewed 2026-04-23 · How we verify

Sham, no injection

This is a sham treatment with no active pharmaceutical ingredient, designed as a control in clinical trials.

At a glance

Mechanism of action

The sham treatment is used to provide a baseline for comparison against the actual drug being tested, ensuring that observed effects are due to the drug and not placebo effects or other variables.

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

• Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP) (PHASE2)
• A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease (PHASE3)
• Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease (PHASE3)
• Extracorporeal Shockwave Therapy and Platelet-Rich Plasma for Midportion Achilles Tendinopathy (NA)
• A Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Choroidal Neovascularization Secondary to Pathologic Myopia (PHASE3)
• Physical Exam, Static & Dynamic Ultrasound Assessment, & Treatment of Thoracolumbar Fascia (TLF) Mediated Low Back Pain (NA)
• Postop Pain Management in Pituitary Tumour Patients (PHASE4)
• Perioperative Multimodal Analgesia for Supratentorial Craniotomy (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.